Skip to content

APOTHEEK VERLINDEN: what changed

BE 0429.633.487NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€45,540
2024 · €79,663-€34,123
Equity
€666,668
2024 · €621,128+€45,540
Cash
€61,881
2024 · €106,958-€45,077
Balance sheet total
€910,584
2024 · €883,642+€26,942

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€121,933

    up €121,933 (+48.3%), from €252,689 to €374,622

    of which Other amounts receivable: +€124,678

  • Stocks and contracts -€47,266

    down €47,266 (-13.5%), from €351,325 to €304,059

  • Cash -€45,077

    down €45,077 (-42.1%), from €106,958 to €61,881

    mainly Receivables within one year (-€121,933) and Investment in fixed assets (net) (-€32,338)

Equity and liabilities
  • Profit (loss) carried forward +€45,540

    up €45,540 (+75.8%), from -€60,115 to -€14,575

  • Tax, wage and social debts -€19,599

    down €19,599 (-33.8%), from €58,050 to €38,451

    of which Remuneration and social security: -€11,138

Income statement
  • Gross operating margin -€47,563

    down €47,563 (-9.2%), from €518,208 to €470,645

  • Staff costs -€12,989

    down €12,989 (-3.4%), from €385,525 to €372,536

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €79,663
Gross operating margin -€47,563
Staff costs +€12,989
Depreciation -€767
Other operating charges +€716
Financial income -€571
Financial charges +€1,072
Taxes -€0
Result 2025 €45,540
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€12,739
Investment -€32,338
Financing €0
Cash 2024 €106,958
Net result for the year +€45,540
Depreciation +€40,264
Stocks and contracts +€47,266
Receivables within one year -€121,933
Deferred charges and accrued income -€5,279
Trade debts -€8,631
Tax, wage and social debts -€19,599
Other debts +€7,272
Accrued charges and deferred income +€2,361
Investment in fixed assets (net) -€32,338
Cash 2025 €61,881
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €883,642 €910,584 +€26,942 +3.0%
Fixed assets 21/28 €153,462 €145,536 -€7,926 -5.2%
Tangible fixed assets 22/27 €153,262 €145,336 -€7,926 -5.2%
Land and buildings 22 €13,683 €41,212 +€27,529 +201%
Plant, machinery and equipment 23 €69,302 €52,147 -€17,155 -24.8%
Furniture and vehicles 24 €4,837 €6,709 +€1,872 +38.7%
Other tangible fixed assets 26 €65,441 €45,269 -€20,172 -30.8%
Financial fixed assets 28 €200 €200 = 0.0%
Current assets 29/58 €730,180 €765,048 +€34,868 +4.8%
Stocks and contracts in progress 3 €351,325 €304,059 -€47,266 -13.5%
Stocks 30/36 €351,325 €304,059 -€47,266 -13.5%
Amounts receivable within one year 40/41 €252,689 €374,622 +€121,933 +48.3%
Trade receivables 40 €147,304 €144,560 -€2,744 -1.9%
Other amounts receivable 41 €105,385 €230,062 +€124,678 +118%
Cash at bank and in hand 54/58 €106,958 €61,881 -€45,077 -42.1%
Deferred charges and accrued income 490/1 €19,208 €24,487 +€5,279 +27.5%
Total equity and liabilities 10/49 €883,642 €910,584 +€26,942 +3.0%
Equity 10/15 €621,128 €666,668 +€45,540 +7.3%
Contributions 10/11 €177,000 €177,000 = 0.0%
Capital 10 €177,000 €177,000 = 0.0%
Issued capital 100 €177,000 €177,000 = 0.0%
Reserves 13 €504,243 €504,243 = 0.0%
Non-distributable reserves 130/1 €17,700 €17,700 = 0.0%
Legal reserve 130 €17,700 €17,700 = 0.0%
Distributable reserves 133 €486,543 €486,543 = 0.0%
Profit (loss) carried forward 14 -€60,115 -€14,575 +€45,540 +75.8%
Amounts payable 17/49 €262,514 €243,916 -€18,598 -7.1%
Amounts payable within one year 42/48 €262,514 €241,556 -€20,958 -8.0%
Trade debts 44 €204,171 €195,540 -€8,631 -4.2%
Suppliers 440/4 €204,171 €195,540 -€8,631 -4.2%
Taxes, remuneration and social security 45 €58,050 €38,451 -€19,599 -33.8%
Taxes 450/3 €8,461 €0 -€8,461 -100.0%
Remuneration and social security 454/9 €49,589 €38,451 -€11,138 -22.5%
Other amounts payable 47/48 €293 €7,565 +€7,272 +2,480%
Accrued charges and deferred income 492/3 - €2,361 +€2,361
Non-recurring operating income 76A €0 - =
Remuneration, social security and pensions 62 €385,525 €372,536 -€12,989 -3.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €39,497 €40,264 +€767 +1.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €0 - =
Other operating charges 640/8 €6,226 €5,510 -€716 -11.5%
Gross operating margin 9900 €518,208 €470,645 -€47,563 -9.2%
Operating profit (loss) 9901 €86,959 €52,335 -€34,624 -39.8%
Financial income 75/76B €766 €194 -€571 -74.6%
Recurring financial income 75 €766 €194 -€571 -74.6%
Financial charges 65/66B €8,062 €6,989 -€1,072 -13.3%
Recurring financial charges 65 €8,062 €6,989 -€1,072 -13.3%
Profit (loss) for the period before taxes 9903 €79,663 €45,540 -€34,123 -42.8%
Income taxes 67/77 €0 €0 +€0
Profit (loss) for the period 9904 €79,663 €45,540 -€34,123 -42.8%
Profit (loss) for the period to be appropriated 9905 €79,663 €45,540 -€34,123 -42.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€666,668 to €666,668

Midpoint €666,668 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €666,668
Indication €666,668

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€666,668
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€666,668

Capitalised earnings

net result for the year (9904)
2025
€45,540
2024
€79,663
2023
-€144,316
excluding non-recurring income and charges
-€153,594
2022
€4,538
2021
€399,901
excluding non-recurring income and charges
-€166,604
Average result, excluding non-recurring income and charges
-€9,464
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.